Skip to main content
. 2010 May 24;5(5):e10799. doi: 10.1371/journal.pone.0010799

Figure 1. Flow chart on numbers of patients included in the anti-tuberculosis drug resistance surveillance in 2004 in Heilongjiang province, China, and followed up in 2008.

Figure 1